Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| McGill University | OTHER |
| Institut de Recherches Cliniques de Montreal | OTHER |
Not provided
Not provided
Not provided
Not provided
Type 1 Diabetes management is requiring and implies numerous lifestyle modifications. Insulin restriction to control weight is a frequent phenomenon, affecting up to 40% of PWT1D. Broadly, purging or binge eating behaviors are also frequently disordered eating behaviors (DEB) in people living with a Type 1 Diabetes (associated or not with restrictive eating behaviors). In a study on adolescents with T1D, the prevalence of moderate or high level of DEB ranged from 21% to 32%. Moreover, the presence of binge eating behavior seems to be associated with higher anxiety and depression levels.
Omitting insulin for weight control has been associated with the highest rates of retinopathy and nephropathy when compared to other weight control behaviors and to increase the risk of mortality by 3.2 times and decrease life spans from an average of 58 to 44 years at 11-year follow-up. Moreover, insulin misuse may be much more complex behavior than just the need for weight control. These behaviors may also involve increased distress, loss of control, and feelings of regret, guilt, and shame.
Interestingly, most studies of eating disorders and type 1 diabetes use question regarding insulin omission as a surrogate marker for eating disorders and disordered eating. For instance, the question used in the BETTER registry are: "In the past 12 months, did you intentionally omit insulin injections with the objective of losing weight?" or "In a typical week, how often do you miss an insulin dose?". However, the validity and robustness of such a marker have not been specifically investigated yet.
Our study objectives are : 1) To confirm that participants who reported intentionally omitting insulin had significantly more disordered eating behavior (based on the review of food records available); 2) To compare the prevalence and the severity of physical and mental health comorbidities (e.g., diabetes micro and macrovascular complications, glycated hemoglobin levels, current and past psychiatric disorders, distress related to diabetes) in people living with diabetes having or not declared to intentionally omit insulin; 3) To establish, using machine learning techniques, the main factors associated with intentional insulin omission behavior, taking into account biological, anthropometric and psychometric factors.
Our main hypotheses:
Statistical Analysis:
The normality of the data distribution will be checked for each value using a graphical analysis of the distribution and a Kolmogorov-Smirnov test before parametric tests are performed. A description of the characteristics of the participants included in this study will be performed. Continuous variables will be presented by the mean and standard deviation for normal distributions, median and range for others. Categorical variables will be presented by the number and percentage of each modality. The level of significance of the tests must be equal or lower than 0.05. The risk of alpha error is set at 0.05, with Bonferroni correction if necessary.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Having omit insulin | Patients with type 1 diabetes who responded to the BETTER survey that they intentionally forgot their insulin. | ||
| Not intentionally omit insulin | Patients with type 1 diabetes who responded to the BETTER survey that they did not intentionally omit their insulin, but they did omit it. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Insulin omission | "In the past 12 months, did you intentionally omit insulin injections with the objective of losing weight?" "In a typical week, how often do you miss an insulin dose?" | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Demographic data | Baseline | |
| Diabetes history | Baseline | |
| Current treatment for diabetes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
This retrospective study will include data from people living with type I diabetes (adolescents and adults) who participated in the baseline phase of the BETTER registry.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sylvain Iceta, MD, PhD | Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IUCPQ | Québec | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| D003920 | Diabetes Mellitus |
| D005247 | Feeding Behavior |
| D000092862 | Psychological Well-Being |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
If any.
| Baseline |
| Total daily dose of insulin | In units. | Baseline |
| Complications of diabetes | Like hypoglycemia, diabetic ketoacidosis (DKA), micro- and macro-vascular. | Baseline |
| Comorbidities | Including celiac disease. | Baseline |
| Medication | The medication that is being taken for depression, if any. | Baseline |
| Depression Scale (PHQ-9) | The Patient Health Questionnaire (9 items). | Baseline |
| Dietary intake : 24 hours recalls | Macronutrients per meal total per day. | Baseline |
| Dietary intake : all food items in each meal | Including portions and macronutrients. | Baseline |
| Type of diet | If any. | Baseline |
| Number of meals | Per day. | Baseline |
| Body Mass Index (BMI) | Weight and height will be combined to report BMI in kg/m^2. | Baseline |
| Waist circumference | In cm. | Baseline |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D001522 | Behavior, Animal |
| D001519 | Behavior |
| D010549 | Personal Satisfaction |